New Standard for Metastatic Castration-Sensitive Prostate Cancer?

(MedPage Today) -- Hormonal therapies combined with chemotherapy significantly improved radiographic progression-free survival (rPFS) for men with de novo metastatic castration-sensitive prostate cancer (mCSPC), results from a phase III study showed...